- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 273.54M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 273.22M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 247.16M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $549.93M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $446.29M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $68.25M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $61.12M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$288.82M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $555.12M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $5.86B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.34B |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $2.71B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $23.79B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $22.89B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $14.75B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.46B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $39.58B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $29.56B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.67B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $12.6B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $64.25B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $53.34B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$6.59 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.24 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$6.59 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.24 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.71B |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $957.18M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.8B |
| Net Income | Q1 2026 · Mar 31, 2025 | $305.73M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$15.65M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $371.96M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.27B |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $495.18M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.97B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.82B |